Biocentral Laboratories Limited – Trademark Portfolio
Entity Type: 03
Biocentral Laboratories Limited holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 7 filings in this category. The portfolio also extends into Class 4 (Lubricants & Fuels) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include AQUABOOST and BLAZETAMER. The owner is based in South Australia.
22 Phillips Street
Thebarton
South Australia 5031 , AU
Showing of trademarks Trademarks
Trademark Classifications
Biocentral Laboratories Limited's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Industrial oils and greases; lubricants; dust absorbing, wetting and binding compositions
Frequently Asked Questions
How many trademarks does Biocentral Laboratories Limited have?
Biocentral Laboratories Limited has 9 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 1 cancelled.
What trademark classes does Biocentral Laboratories Limited file in?
Biocentral Laboratories Limited files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 4 (Lubricants & Fuels). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are Biocentral Laboratories Limited's most well-known trademarks?
Biocentral Laboratories Limited's registered trademark portfolio includes well-known marks such as AQUABOOST and BLAZETAMER. These are among 2 currently registered trademarks in the portfolio.
What is Biocentral Laboratories Limited's trademark registration success rate?
Biocentral Laboratories Limited has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.